about-me variable
BioReperia invites you to their event

How to evaluate drug candidates in a novel in vivo system - pros and cons

About this event

The road to launching a novel drug to the market is long and winding. Many different methods and models are used during the development pipeline to evaluate the drug candidates. The Zebrafish xenograft, ZTX™ model for evaluation of efficacy is one of them and one that is fairly new and for many unknown.

In this webinar we will present the ZTX model and discuss the pros and cons and compared to other models commonly used in drug development today like mice in vivo, organoids and in vitro models. 

Speaker is Dr Anna Erkstam, PhD

BioReperia, CEO

Hosted by

  • Team member
    T
    Anna Erkstam CEO @ BioReperia

BioReperia

We are a contract research organization (CRO) that increase the speed for your pre-clinical drug discovery.